Best Potential Tech and AI Stocks

Results

27

3 new

Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.

27 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$540.160.7%37.9%US$12.1bUS$678.069.763.7%n/aPharmaceuticals & Biotech
TVTX
US$65.966.1%267.1%US$6.0bUS$74.1410.553.1%n/aPharmaceuticals & Biotech
LITE
US$827.60-11.2%614.1%US$78.3bUS$1,148.3024.6104.4%n/aTech
TGTX
US$51.694.4%82.6%US$7.1bUS$69.7116.621.3%n/aPharmaceuticals & Biotech
AV1
AU$0.068-6.8%-57.5%AU$63.9mAU$0.166.6107.8%n/aSoftware
SNDX
US$20.774.9%32.0%US$1.8bUS$37.917.469.5%n/aPharmaceuticals & Biotech
PGEN
US$7.164.5%123.1%US$2.4bUS$14.5029.955.4%n/aPharmaceuticals & Biotech
COHR
New
US$287.47-19.2%232.1%US$60.0bUS$416.0973.143.9%n/aTech
INSM
US$130.66-1.2%0.9%US$28.1bUS$200.0525.167.0%n/aPharmaceuticals & Biotech
FN
US$454.55-20.5%62.1%US$17.3bUS$734.1134.421.4%n/aTech
PRAX
US$386.19-0.04%753.5%US$10.3bUS$633.168.071.7%n/aPharmaceuticals & Biotech
MRKR
US$1.2911.2%11.2%US$19.2mUS$7.878.073.4%n/aPharmaceuticals & Biotech
ARDX
US$4.031.5%-32.7%US$976.8mUS$12.902.261.5%n/aPharmaceuticals & Biotech
AEIS
US$294.31-12.8%99.2%US$12.6bUS$429.0853.443.1%0.1%Tech
ANAB
US$59.264.0%194.1%US$1.7bUS$87.097.648.1%38.0%Pharmaceuticals & Biotech
ELS
AU$6.31-2.8%265.8%AU$1.4bAU$9.51133.049.8%n/aTech
IONS
US$60.807.6%42.0%US$9.9bUS$88.0011.668.7%n/aPharmaceuticals & Biotech
STX
US$832.56-5.2%425.6%US$204.8bUS$1,125.0059.330.4%0.4%Tech
CLS
CA$416.59-11.8%64.2%CA$49.7bCA$680.9431.134.6%n/aTech
ORCL
US$143.81-6.2%-38.8%US$411.3bUS$246.4324.424.4%1.4%Software
ZYME
New
US$27.219.1%90.0%US$1.9bUS$40.3352.039.6%n/aPharmaceuticals & Biotech
COG
UK£0.330%26.9%UK£15.4mUK£0.621.656.0%n/aHealthcare
FLEX
US$113.03-9.2%130.2%US$44.4bUS$160.5042.944.9%n/aTech
NET
US$291.88-6.3%51.1%US$107.3bUS$333.5541.448.1%n/aSoftware
Page 1 of 1